With suspected myocardial infarction, every second counts. Hence, it is essential to rule in or rule out non-ST-segment elevation myocardial infarction (NSTEMI) as soon as possible as Acute Coronary Syndrome (ACS) presents a significant mortality risk. This article describes the features and benefits of a new device for rapid diagnosis of heart attack at the point-of-care. Current scenario: In the acute setting, the ECG system identifies life-threatening ST segment elevation myocardial infarction (STEMI).
However, for most patients with suspicion of ACS and no persistent ST-elevation , there is the need to measure cardiac markers, preferably troponin. Yet it can take over an hour to get the results back from the laboratory. Biomarker: Cardiac Troponin I is a highly specific protein biomarker that is secreted during the necrosis of myocardia in the event of heart attack. They are…
